Factors Associated with the Decision to Decline Chemotherapy in Metastatic Non-Small Cell Lung Cancer
(1) Background: Disparities in cancer treatment and outcomes have long been well-documented in the medical literature. With the eruption of advances in new treatment modalities, the long-existing disparities are now being further uncovered and brought to the attention of the medical community. While...
Main Authors: | Iktej Singh Jabbal, Saad Sabbagh, Mira Itani, Barbara Dominguez, Mohamed Mohanna, Valencia Henry, Hong Liang, Diana Saravia, Tiffany George, Zeina Nahleh, Evan Alley, Rafael Arteta-Bulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/6/1686 |
Similar Items
-
Impact of COVID-19 on Cancer-Related Care in the United States: An Overview
by: Iktej Singh Jabbal, et al.
Published: (2023-01-01) -
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?
by: Nadeem Bilani, et al.
Published: (2022-12-01) -
Disparities in Metabolic Conditions and Cancer Characteristics among Hispanic Women with Breast Cancer: A Multi-Institutional Study
by: Iktej S. Jabbal, et al.
Published: (2022-07-01) -
Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis
by: Nadeem Bilani, et al.
Published: (2021-02-01) -
Racial Disparities among Asian American, Native Hawaiian, and Other Pacific Islander Patients with Cancer Who Refuse Recommended Radiation Therapy or Surgery
by: Brianna Lau, et al.
Published: (2023-06-01)